Latest filing published 02 Mar 2026 for BioAtla, Inc., €571. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Richard A. Waldron (finance chief) discloses dealings in BioAtla, Inc. to SEC (Form 4). Over a trading history stretching from 14 June 2021 to 28 February 2026, the count stands at 34 filings.
On the market, this insider has only sold: 3 sales, €229k in total. The rest of the record consists of 30 share grants.
The latest filing, published on 2 March 2026, reports a share grant of €571 in BioAtla, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 34 declarations